Lake Street downgraded LifeVantage to Hold from Buy with a $5 price target. Q3 results came in below expectations and while management maintained its prior FY26 guidance framework, it now expects results to come in near the low end of the range, the analyst tells investors. The firm, which is lowering estimates below the company's updated outlook, says that while valuation "remains inexpensive," it believes revenue headwinds are likely to persist over at least the next two quarters, limiting upside potential.
